Phase I dose-escalation study to determine the safety, tolerability, preliminary efficacy and pharmacokinetics of an intratumoral injection of tigilanol tiglate (EBC-46)

Benedict J. Panizza, Paul de Souza, Adam Cooper, Aflah Roohullah, Christos S. Karapetis, Jason D. Lickliter

    Research output: Contribution to journalArticlepeer-review

    13 Citations (Scopus)

    Fingerprint Dive into the research topics of 'Phase I dose-escalation study to determine the safety, tolerability, preliminary efficacy and pharmacokinetics of an intratumoral injection of tigilanol tiglate (EBC-46)'. Together they form a unique fingerprint.

    Medicine & Life Sciences

    Chemical Compounds